Why we own Maxiparts Ltd (ASX:MXI) shares
Rob Miller
September 22, 2023
NAOS’ Robert Miller dives into the case for Maxiparts Ltd (ASX:MXI), and offers an overview of Supply Network (ASX:SNL) and Bapcor (ASX:BAP).
Get expert investment analysis on the Australian stockmarket, economy and property from Rask Media’s chosen fund managers, selected analysts and writers. Stay up to date with your preferred experts by creating a free Rask account.
The Match Out: S&P/ASX 200 (INDEXASX: XJO) knocked as the Fed leaves the door ajar on rates
James Gerrish
September 21, 2023
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.37% to 7065.20.
The best time to invest your money
Cameron Gleeson
September 21, 2023
No matter how experienced an investor you are, the decision of when to invest money can naturally provoke a feeling of uncertainty or apprehension.
The Match Out: Energy and Resources weigh on the index as traders wait on the Fed
James Gerrish
September 20, 2023
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.46% to 7163.30.
Price-to-earnings ratio: navigating ETF valuations
Patrick Poke
September 20, 2023
The price-to-earnings (P/E) ratio is one of the most commonly used metrics in financial analysis as it helps investors understand and compare company valuations.
Why We’re Bullish on Resmed – A Deeper Dive into GLP-1 Treatments
Daniel Ortisi
September 20, 2023
The Resmed CDI (ASX: RMD) share price is down over 30% over the past 12 months as analysts and investors weigh up the long-term impact of GLP-1 treatments on RMD’s obstructive sleep apnea (OSA) market.
Connecting growth to decarbonisation
Jowell Amores
September 20, 2023
Global energy markets will need to evolve dramatically over the next three decades. Worldwide, the population is forecast to grow by nearly 2 billion1 and global living standards are expected to rise as per capita consumption increases – and all this against the backdrop of a growing push towards decarbonisation.
S&P/ASX 200 (INDEXASX:XJO) slides ahead of Federal Reserve meeting
James Dunn
September 20, 2023
The local share market fell for a second straight day on Tuesday, ahead of a flurry of central bank meetings, and following the release of a set of minutes from the Reserve Bank of Australia that were taken as implying that the local central bank is considered raising rates.
The Match Out: Subdued session ahead of 3 key central bank decisions
James Gerrish
September 19, 2023
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.47% to 7196.60.
Why we own Maxiparts Ltd (ASX:MXI) shares
September 22, 2023
NAOS’ Robert Miller dives into the case for Maxiparts Ltd (ASX:MXI), and offers an overview of Supply Network (ASX:SNL) and Bapcor (ASX:BAP).
The Match Out: S&P/ASX 200 (INDEXASX: XJO) knocked as the Fed leaves the door ajar on rates
September 21, 2023
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.37% to 7065.20.
The best time to invest your money
September 21, 2023
No matter how experienced an investor you are, the decision of when to invest money can naturally provoke a feeling of uncertainty or apprehension.
The Match Out: Energy and Resources weigh on the index as traders wait on the Fed
September 20, 2023
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.46% to 7163.30.
Price-to-earnings ratio: navigating ETF valuations
September 20, 2023
The price-to-earnings (P/E) ratio is one of the most commonly used metrics in financial analysis as it helps investors understand and compare company valuations.
Why We’re Bullish on Resmed – A Deeper Dive into GLP-1 Treatments
September 20, 2023
The Resmed CDI (ASX: RMD) share price is down over 30% over the past 12 months as analysts and investors weigh up the long-term impact of GLP-1 treatments on RMD’s obstructive sleep apnea (OSA) market.
Connecting growth to decarbonisation
September 20, 2023
Global energy markets will need to evolve dramatically over the next three decades. Worldwide, the population is forecast to grow by nearly 2 billion1 and global living standards are expected to rise as per capita consumption increases – and all this against the backdrop of a growing push towards decarbonisation.
S&P/ASX 200 (INDEXASX:XJO) slides ahead of Federal Reserve meeting
September 20, 2023
The local share market fell for a second straight day on Tuesday, ahead of a flurry of central bank meetings, and following the release of a set of minutes from the Reserve Bank of Australia that were taken as implying that the local central bank is considered raising rates.
The Match Out: Subdued session ahead of 3 key central bank decisions
September 19, 2023
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.47% to 7196.60.
Like our podcast? Get Owen's weekly newsletter.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.